help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Recent Advances in Melanoma Biology
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perlis, C.
Right arrow Articles by Herlyn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perlis, C.
Right arrow Articles by Herlyn, M.
The Oncologist, Vol. 9, No. 2, 182–187, April 2004
© 2004 AlphaMed Press


ORIGINAL PAPER
Melanoma and Cutaneous Malignancies

Recent Advances in Melanoma Biology

Cliff Perlisa, Meenhard Herlynb

a Department of Dermatology, Brown Medical School, Providence, Rhode Island, USA; b Wistar Institute, Philadelphia, Pennsylvania, USA

Correspondence: Meenhard Herlyn, D.V.M., D.Sc., The Wistar Institute, 3601 Spruce Street, Philadelphia, Pennsylvania 19104, USA. Telephone: 215-898-3959; Fax: 215-898-0980; e-mail: herlynm{at}wistar.upenn.edu

The incidence and mortality rates of melanoma have increased at annual rates of 2%–3% for the last 30 years. Disseminated disease is largely refractory to cytotoxic chemotherapy and is almost universally fatal. Several recent advances in melanoma biology offer new strategies for potentially treating this aggressive malignancy. This review focuses on three significant advances involving tumor initiation, etiology, and progression. New experimental models reveal a direct role for UV-B light in initiating melanomas in human skin. Studies on E- and N-cadherin elucidate the importance of local homeostatic mechanisms in regulating tumor progression. Finally, several discoveries concerning apoptotic mechanisms in melanoma suggest strategies for future treatments.

Key Words. Melanoma • Cell adhesion molecules • Apoptosis • Ultraviolet radiation




This article has been cited by other articles:


Home page
Cancer Res.Home page
V. N. Ivanov, H. Zhou, and T. K. Hei
Sequential Treatment by Ionizing Radiation and Sodium Arsenite Dramatically Accelerates TRAIL-Mediated Apoptosis of Human Melanoma Cells
Cancer Res., June 1, 2007; 67(11): 5397 - 5407.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Roth, A. Akalu, A. Zelmanovich, D. Policarpio, B. Ng, S. MacDonald, S. Formenti, L. Liebes, and P. C. Brooks
Recombinant {alpha}2(IV)NC1 Domain Inhibits Tumor Cell-Extracellular Matrix Interactions, Induces Cellular Senescence, and Inhibits Tumor Growth in Vivo
Am. J. Pathol., March 1, 2005; 166(3): 901 - 911.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2004 by AlphaMed Press.